CD Flashcards

1
Q

A 77 year old recently immigrated from Pakistan to Canada. He is previously healthy and presents with 2 months of a new cough, hoarse voice, and weight loss. He has been diagnosed with TB. He has a positive sputum specimen by AFB smear, 2+, positive NAAT. Culture is still pending. CXR reveals small lesions in the left upper lobe, though no cavitary lesions. CT neck/chest reveals bilateral diffuse thickening of the vocal cords. He lives with 5 family members in a 3-bedroom house in a suburban neighborhood of a large multicultural city. He does not work.
1. List 4 factors that make this case highly infectious.
2. How should this individual be managed (4 items)?
3. You determine that close contacts should be followed up. List 6 factors that should be considered for contact investigations and management.
4. The WHO End TB strategy seeks to reduce the prevalence of TB to less than 10 per 100,000 globally by 2035. List 5 elements of TB elimination and control that can help Canada achieve this goal.

A
  1. List 4 factors that make this case highly infectious.
    Smear positive
    NAAT positive
    Respiratory symptoms including a cough
    Upper lobe involvement seen on x-ray
    Laryngeal TB
  2. How should this individual be managed (4 items)?
    Treatment with rifampin, isoniazid, pyrazinamide, ethambutol x 2 months, then isoniazid and rifampin for another 4 months
    Weekly sputum samples
    Home isolation until smear negative
    Monthly follow-up appointments with TB services
    Airborne precautions in healthcare settings
  3. You determine that close contacts should be followed up. List 6 factors that should be considered for contact investigations and management.
    Age of the contact, specifically if 5 years or younger
    If they are immunocompromised, for example taking a TNF inhibitor
    If they have HIV
    History of BCG vaccination
    Any symptoms of active TB such as a new cough
    Duration of exposure
    Exposure setting, such as indoor versus outdoor, proximity to the case, and air quality or ventilation
  4. The WHO End TB strategy seeks to reduce the prevalence of TB to less than 10 per 100,000 globally by 2035. List 5 elements of TB elimination and control that can help Canada achieve this goal.
    Primary prevention - improved access to adequate housing for Inuit, First Nations, and newcomer populations
    Secondary prevention - screening programs with chest x-ray for higher risk population such as immigrants
    Tertiary prevention - early diagnosis and treatment by improving access to primary care and specialist TB clinics, to reduce transmission to others
    Timely contact tracing and contact investigation/management
    Strengthening the Canadian TB Reporting System for ongoing surveillance
    Public education on the symptoms and risks of TB
    Improved adherence to treatment for active and latent TB through DOT or community-led initiatives

Other Categories for TB Control
- Prevention
- Diagnosis
- Treatment
- Contact Tracing
- Surveillance
- Targeted programs (CXR on IMEs)
- SDOH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

There is a new lab-confirmed hep B case
1. List 6 important elements to include in the case investigation
2. List 4 elements of case management
3. List 4 criteria for identifying close contacts

A
  1. List 6 important elements to include in the case investigation
    Risk factors
    Was their mother hep B positive when pregnant with the case?
    Any hep B positive household contacts (acute or chronic carrier)
    Any unprotected sexual contact with someone who is hep B positive or multiple sexual partners?
    gbMSM?
    Injection drug use? Sharing needles or other supplies i.e. cookers, straws, pipes
    Current or past incarceration?
    Receipt of blood/tissue/organ donation?
    Invasive medical or dental procedure in an endemic country?
    Frequent recipient of blood products?
    Skin piercings, tattoos, or acupuncture with unsterile equipment or technique?
    Invasive medical or dental procedure? E.g. hemodialysis
    Immigration from or to a hep B endemic country (prevalence 8%)
    Determine co-infection with other blood borne infections
    Determine immunization history
    Determine pregnancy status
    Determine history of blood, tissue, or organ donation
    Determine occupation
  2. List 4 elements of case management
    Education on signs and symptoms, modes of transmission, and ways to reduce risk of transmission
    Refer to hepatology or ID
    Routine IPC precautions for hospitalized cases
    Re-check HBsAg and anti-HBs in 6 months
  3. List 4 criteria for identifying close contacts
    Living in the same household
    Sharing needles
    Sexual partners
    People who have shared personal care items (e.g. razors, toothbrushes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. List 5 elements of an animal exposure rabies risk assessment.
  2. What is the regimen for rabies post-exposure prophylaxis from a high risk exposure? How does this change if the victim received an adequate pre-exposure prophylaxis series? For immunocompromised people?
  3. List 4 possible interventions for a rabies control program in an area endemic for human and animal rabies
A
  1. List 5 elements of an animal exposure rabies risk assessment.
    Date and time of exposure
    Location of exposure
    Type of animal
    Based on local epidemiology, is the type of animal a known reservoir for rabies?
    If not a known reservoir, could the animal have come into contact with a rapid animal?
    Was the attack provoked?
    Did the animal have clinical signs of rabies i.e. encephalopathy, self-mutilation, coma
    Is the animal available for observation?
    Has the victim previously received rabies vaccine?
    Do we know the victim’s RFFIT titre (greater than 0.5 IU/mL?)?
  2. What is the regimen for rabies post-exposure prophylaxis from a high risk exposure? How does this change if the victim received an adequate pre-exposure prophylaxis series? For immunocompromised people?
    4-dose regimen for immunocompetent unvaccinated patient: vaccine 1.0mL IM on days 0,3,7,and 14
    2-dose regimen if previously vaccinated on days 0 and 3, then check titres
    5-dose regimen if immunocompromised on days 0,3,7,14, and 28
    Note: PrEP regime is 3 doses on days 0,7,and 28
  3. List 4 possible interventions for a rabies control program in an area endemic for human and animal rabies
    Public education campaigns on animal safety and management for animal bites
    Pre-exposure vaccination
    Post-exposure vaccination
    Animal vaccination
    Timely access to healthcare following an animal bite
    Surveillance for rabies cases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. Your local influenza surveillance systems indicate that seasonal influenza cases are much higher this year compared to average cases in previous years. List 4 possible reasons for this.
  2. List 3 types of influenza surveillance used in Canada and give an example of each
A
  1. Your local influenza surveillance systems indicate that seasonal influenza cases are much higher this year compared to average cases in previous years. List 4 possible reasons for this.
    Agent - Mismatch between the circulation strain and vaccine strain
    Host - Lower vaccination compared to previous years
    Physical Environment - Unseasonably cold weather leading to respiratory viruses surviving longer on surfaces and people spending more time together indoors
    Social Environment - Mass gatherings or holidays with many social gatherings
    Increased testing
    Change in test sensitivity
    Increased surveillance
    Change in case definition
  2. List 3 types of influenza surveillance used in Canada and give an example of each
    Syndromic - FluWatch, school absenteeism, LTC respiratory illness monitoring
    Passive - lab reporting
    Sentinel - FluWatch, Sentinel Practitioner Surveillance Network for vaccine effectiveness, Tarrant (AB)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A lab-confirmed case of measles has been identified in a 30 year old male.

  1. List 5 steps of your case investigation.
  2. What are your next steps for case management (3)
  3. What are the criteria for a susceptible contact? (6)
  4. Household contacts have been identified: (i) case’s 30 year old wife who is 16 weeks pregnant and received all childhood vaccines in Canada , (ii) a 2 year old child who is unvaccinated, (iii) a 6 year old child who received 1 measles containing vaccine at age 14 months, (iv) and the case’s 58 year old mother who has a diagnosis of hypertension but otherwise healthy with childhood vaccination is unknown. What type of post-exposure prophylaxis do you offer each contact?
  5. What criteria do you consider for exclusion orders for contacts?
  6. What variables do you need to know to calculate critical vaccination coverage against measles? (2)
A
  1. List 5 steps of your case investigation.
    Are there clinical symptoms consistent with measles such as fever, maculopapular rash on the head that spreads inferiorly, cough, conjunctivitis, coryza, Koplik spots?
    Are there signs or symptoms of severe illness such as encephalitis or seizure?
    Any travel during the incubation period (21 days prior to onset of fever)
    What is the case’s occupation?
    Any contact with a known or probable case of measles?
    Has the case previously received any measles-containing vaccines?
    Did the case attend any healthcare settings during the period of communicability (4 days prior to rash until 4 days after rash onset)?
  2. What are your next steps for case management (3)
    Isolation until 4 days after the rash appeared
    If hospitalized or seeking healthcare, ensure airborne, droplet IPC precautions are used
    Initiate contact tracing
  3. What are the criteria for a susceptible contact? (6)
    Shared airspace for any length of time with the case, including 2 hours after the case left the airspace and
    No measles-containing vaccines
    Less than 2 doses of measles-containing vaccine for adults who are healthcare workers, military personnel, or students
    Less than 2 valid doses of measles-vaccine for children and adolescents ages 1-17 (2 doses administered after 12 months old at least 4 weeks apart (MMR) or 6 weeks apart (MMRV)
    No history of lab-confirmed measles
    No prior serologic evidence of immunity (IgG >200 U/mL)
  4. Household contacts have been identified: (i) case’s 30 year old wife who is 16 weeks pregnant and received all childhood vaccines in Canada , (ii) a 2 year old child who is unvaccinated, (iii) a 6 year old child who received 1 measles containing vaccine at age 14 months, (iv) and the case’s 58 year old mother who has a diagnosis of hypertension but otherwise healthy with childhood vaccination is unknown. What type of post-exposure prophylaxis do you offer each contact?
    Wife who is 16w pregnant - Ig up to 6 days after initial exposure
    2 year old child unvaccinated - 1 dose MMR(V) at anytime, Ig up to 6 days after initial exposure
    6 year old child 1 vaccine - 1 dose MMR(V) at anytime
    58 year old mother with hypertension assumed to not have received a measles containing vaccine previously - 1 dose MMR(V) anytime, Ig up to 6 days after initial exposure
  5. What criteria do you consider for exclusion orders?
    Consider exclusion orders for contacts who do not receive PEP for the duration of 5 days after first exposure to 21 days after last exposure or until immunization with measles-containing vaccine, administration of immunoglobulin, or documented lab-confirmed immunity
    Exclude any healthcare workers exposed who only have 1 dose of measles-containing vaccine until there is lab-confirmed immunity and administer 1 dose of measles-containing vaccine immediately
  6. What variables do you need to know to calculate critical vaccination coverage against measles? (2)
    R0 (15-17)
    Vaccine effectiveness (99% with 2 doses)
    * Critical vaccine coverage = (Herd immunity threshold)/(Vaccine effectiveness)
    = [1-(1/R0)]/VE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

There is a vaccine shortage; list 3 methods for pivoting a vaccine program to deal with this resource scarcity

A

There is a vaccine shortage; list 3 methods for pivoting a vaccine program to deal with this resource scarcity

Eligibility - restrict to the highest risk populations (risk of exposure and risk of severe illness)
Scheduling - increase the time interval between doses or provide an incomplete series to a large number of people in the the target population before offering complete series (i.e. mpox 1 dose as PrEP)
Dosing - offer dose-sparing regimens via alternate routes of administration (e.g. lower volumes are usually administered when IM vaccines are given ID, for example mpx, rabies)
Eliminate waste/ manage clinic flow - create plans for unused doses that remain in multidose vials at the end of a clinic due to no-shows or incompletely booked clinics (e.g. offer to workers, call clients from a waitlist, outreach)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe each of the following hep B serological markers: HBsAg, Anti-HBs, anti-HBc, HBeAg, HBV DNA

A

HBsAg: first detectable marker of infection; indicates acute or chronic infection if present for 6+ months
Anti-HBs: immunity from infection or vaccine
anti-HBc IgM: immunity from recent infection (<6 months); occasionally can be detected with exacerbations of chronic infections
HBeAg: indicates acute or chronic infection; associated with level of infectiousness and viral replication
HBV DNA: associated with level of infectiousness; helps determine the need for treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List 5 elements of a possible syphilis control strategy and give an example for each element.

A

Pan-Canadian STBBI Framework for Action 4 pillars
Prevention - sex education in schools, low barrier access to condoms (i.e. free distribution in public spaces), public awareness campaigns including banners on dating/hook up apps and websites
Testing - increase lab capacity for higher volumes of syphilis tests; collaborate with primary care providers, emergency departments, STI clinics, and prenatal care providers to increase routine and opportunistic syphilis screening; change screening guidelines to be more inclusive (additional prenatal screening, newborn screening, youth and young adults); upscale point of care test and treat clinics and dried blood spot testing for areas that do not have resources to support phlebotomy or swabbing
Initiation of Care and Treatment - encourage point-of-care test and treat programs to reduce the potential for loss to follow-up; create care environments that are culturally safe and gender affirming; reduce the barriers to testing and treatment in emergency departments by creating a standardized order set and stocking benzathine penicillin kits in emerg with instructions; increase capacity for complex case management and partner notification
Ongoing Care and Support - Find ways of building trust and encouraging an ongoing care relationship with clients/patients (e.g. peer support workers, collaborate with outreach programs or community-based organizations, incentive programs such as gift cards, communicating via text or social media instead of phone calls)
On a foundation of enabling environment, research and surveillance, knowledge mobilization, and monitoring and evaluation (e.g. reflex lab reporting to Public Health; required reporting from point-of-care testing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

You decide to focus on increasing point-of-care testing test & treat programs, expanding beyond the centralized STI clinic to operate at community health centres, through mobile outreach clinics, and supplying education and supplies to primary care and emergency rooms. List and describe 5 possible indicators that can be used to evaluate this program, with the goal of reducing infectious syphilis rates and eliminating congenital syphilis.

A

You decide to focus on increasing point-of-care testing test & treat programs, expanding beyond the centralized STI clinic to operate at community health centres, through mobile outreach clinics, and supplying education and supplies to primary care and emergency rooms. List and describe 5 possible indicators that can be used to evaluate this program, with the goal of reducing infectious syphilis rates and eliminating congenital syphilis.

Number of partner sites (process indicator/output)
Number of kits distributed (process indicator/output)
Test positivity
Percent of positive tests that receive adequate treatment within 2 weeks (process indicator)
Percent change in syphilis incidence from baseline (outcome indicator)
Incidence of congenital syphilis (outcome indicator)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define “outbreak”

A

Outbreak: an increase in the number of cases of a disease above what is normally expected in a population, usually in a limited geographic area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define PHEIC and list 4 criteria for declaring a PHEIC

A

PHEIC (WHO): “an extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response”.

Must report if 2/4 criteria are met:

The public health impact is serious
The event is unusual or unexpected
There is significant risk of international spread
There is significant risk of international travel or trade restrictions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List 3 reasons why outbreaks might occur

A

Agent: Increased virulence, Increased amount of the infectious agent
Host: Change in host susceptibility
Environment: Enhanced mode of transmission leading to more susceptible people being exposed, Increased host exposure or new portals of entry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List 8 of the 13 criteria of the Erikson-De Wals framework for deciding if a vaccine should be incorporated into a publicly funded program.

A

Disease factors
Does the burden of disease justify a control program?

Vaccine factors
Is the vaccine safe and effective?
Is the vaccine licensed for the proposed use, or will it be off-label?
Are there important research questions that have not been answered? E.g. how long does the vaccine confer immunity?

Program factors
What is the goal? What is the delivery strategy? E.g universal, targeted
Can it be evaluated?
Is it cost effective?
Legal
Ethical
Feasibility

Societal factors
Acceptability
Equity
Conformity - is the program implemented elsewhere?
Political landscape - is there political gain or risk from implementing the program?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List the 5 C’s of vaccine hesitancy

A

Confidence - the confidence that vaccines are effective
Constraints - barriers to accessing vaccination
Complacency - perception that VPDs are not an imminent threat
Collective responsibility - willingness to benefit minimally
Risk Calculation - Individual decision making on if benefits (i.e. protection against hospitalization) outweigh the risks of the vaccination (i.e AEFI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List and describe 6 stakeholders involved in vaccine licensing and programs

A

Health Canada Biologics Radiopharmaceuticals and Genetic Therapies Directorate - license and regulate vaccines in Canada
NACI (National Advisory Committee on Immunization) - Provide recommendations on vaccine programs to provinces and territories
CIC (Canadian Immunization Committee) - evaluate the cost effectiveness of vaccination programs
PHAC / CAEFISS - surveillance on adverse effects following immunization
Brighton Collaborative - sets the international standards for AEFIs
Provincial and territorial governments - make decisions on vaccine policy
Health authorities or local public health - operate vaccine clinics
Primary care providers - administer vaccines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List and describe 2 types of AEFI surveillance systems in Canada

A

CAEFISS - passive surveillance of AEFIS in Canada, submitted via patient or healthcare providers
IMPACT - active surveillance of pediatric hospitalization data for possible AEFIs in 12 pediatric hospitals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

List 5 categories of vaccine components and their purpose

A

Antigen - induces immune response against the pathogen of interest
Adjuvant - improves immunogenicity and duration of protection e.g aluminum hydroxide
Antibiotics - prevent bacterial contamination during manufacturing
Preservative - prevents microbial contamination in multidose vials e.g. thimerosal, formaldehyde
Stabilizers - improve stability and the delivery of the antigen e.g. lactose, gelatin, albumin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

List 5 types of vaccines and one example of each

A

Live attenuated - MMR, varicella, intranasal influenza, BCG, small pox, oral polio, rotavirus, yellow fever
Inactivated - IPV, Hep A, Rabies
Subunit (Can be further categorizes into protein, conjugate, or polysaccharide subcategories)
Protein based subunit - acellular pertussis
Conjugate subunit - Hib, pneumococcal conjugate
Polysaccharide subunit - quadrivalent meningococcal ACYW-135, pneumococcal 23-valent
Recombinant - Hep B, HPV
Toxoid - tetanus, diphtheria
mRNA - COVID spikevax (moderna)
Viral vector - COVID vaxzevira (AZ)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Vaccine schedule in Alberta

A

2 months DTaP-IPV-Hib, HepB, Rotavirus, Pneu-C13
4 months DTaP-IPV-Hib, HepB, Rota, Pneu-C13, MenconC
6 months DTap-IPV-Hib, HepB, Pneu-C13 if high risk, Influenza x2 (4w apart)
12 months MMR-Var, MenconC, Pneu-C13
18 months DTaP-IPV-Hib, MMR-Var
4 years dTap-IPV, MMR-Var if not received at 18m
Grade 6 HepB x2, HPV x2
Grade 9 dTap, MenC-ACYW
Adult dTap q10 years, and 1 dose qPregnancy, Pneumo-P 1 dose age 65+

20
Q

List 5 priority organisms for antimicrobial resistance surveillance in Canada

A

MRSA (methicillin resistant staphylococcus aureus)
VRE (vancomycin resistant enterococcus)
Multidrug resistant Mycobacterium tuberculosis
Multidrug resistant Neisseria gonorrhea
CPOs (carbapenemase producing organisms)

21
Q

List 8 factors that contribute to AMR

A

Overuse of antibiotics
Misuse of antibiotics (e.g. for viral infections)
Prescribing before sensitivity is tested
Stopping before treatment is complete (e.g. TB)
Medical conditions requiring recurrent of chronic antibiotic use (e.g. indwelling catheter leading to recurrent UTIs, CF, chronic wounds)
Prolonged hospitalization and nosocomial infections
Globalization of trade and travel
Use of antibiotics in animal agriculture

22
Q

List 5 elements for a hospital antibiotic stewardship program

A

TRAMPLE
Tracking
Reporting
Accountability Measures
Pharmacy expertise
Leadership commitment
Education

23
Q

List and give an example of 4 levels in the hierarchy of controls

A

Elimination - enhanced cleaning and disinfection, staff screening
Substitution - replace reusable equipment with disposable
Engineering controls - physical distancing, cohorting, improved ventilation, auto-retracting needles
Administrative controls - IPC education for staff, single-site orders
PPE - continuous masking and eye protection

24
Q

List the 3 IPC precautions (other than routine precautions) with pathogens and examples of interventions for each

A

Contact - norovirus, C diff - patient should remain in their room, wear gloves +/- gown, additional cleaning for C. diff and VRE

Droplet - influenza, N. meningitides - patient would wear a mask if leaving the room, HCW mask and eye protection, routine cleaning with daily cleaning for high touch surfaces

Airborne - measles, varicella,TB - negative pressure room, HCW N95, routine cleaning

25
Q

Define the following IPC terms: cleaning, disinfection, sterilization, high-level disinfection, intermediate-level disinfection, and low-level disinfection

A

Cleaning: Physical removal of dirt and grime and some portion of germs

Disinfection: Killing a high percentage of the germs on a surface or rendering them incapable of reproducing (except for bacterial spores)

Sterilization: Process that destroys or eliminates all forms of microbial life present on an object

High-level disinfection: Capable of destroying or irreversibly inactivating all microbial pathogens, but not necessarily large numbers of bacterial spores

Intermediate-level disinfection: destroys vegetative bacteria, mycobacteria, most viruses, and most fungi but not bacterial spores

Low-level disinfection: Destroys vegetative bacteria and some fungi and viruses but not mycobacteria or spores

26
Q

Describe the 3 levels of Spaulding’s classification for medical device reprocessing and examples of equipment in each category

A

Critical - penetrate skin or enter sterile tissue - surgical instruments, implants, biopsy instruments, foot care equipment

Semi-critical - contacts non-intact skin or mucous membrane but doesn’t penetrate them - vaginal speculum, transrectal probe, tonopen

Non-critical - contacts intact skin but not mucous membrane or does not directly touch the patient - ECG machines, pulse oximeters, bedpans, commodes

27
Q

List and describe 5 steps to investigate and manage an IPC Lapse or Medical Device Reprocessing Lapse

A

Identification - receive a complaint from public, regulatory body, surveillance, or reportable disease notification

Initial assessment - send an inspector to the site, observe IPC practice/equipment/lay out, review relevant policies and porotocols, review records and logs, describe deviations from best practices

Categorize the complaint - unsubstantiated, lower risk, high risk, definite deviation

Take action - risk assessment, corrective actions, re-inspection

Notify key stakeholders - patients, Ministry of Health, medical regulatory authorities, public

28
Q

List and describe 6 steps of an outbreak investigation

A

Confirm the existence of an outbreak - determine if the number of cases is higher than expected; rule out artifactual reasons for increase (change in case definition, change in reporting, change in testing etc)
Confirm diagnosis - detect and isolate a causative agent, case investigations
Assemble a team - internal and external stakeholders. E.g. lab, epi, comms, PH nurses, PHIs, imms teams, community orgs, F/P/T partners
Define and find cases - determine a sensitive case definition (agent, person, place time, symptoms)
Perform descriptive epi - identify populations at risk of exposure
Generate and test hypothesis - draw epi curves, calculate attack rates, conduct a case-control study
Implement IP&C measures - isolation, quarantine, environmental controls
Initiate and maintain surveillance - consider active surveillance (asymptomatic prevalence testing)
Communicate findings - to the public, at risk groups, leadership/P/T
End outbreak and debrief - determine threshold for declaring the end of an outbreak (2 incubation periods); conduct an after action review

29
Q

List 4 agencies involved in an inter-provincial food-borne illness outbreak investigation, and describe the role of each

A

CFIA – inspection of food, livestock, feed, plants, seeds; food safety investigations (tracing), recalls
Health Canada – health risk assessments to the CFIA and P/T, public communication
PHAC – coordinates the outbreak investigation
NML – reference services for strain identification and characterization, surveillance, disseminate information via PulseNet Canada and the National Enteric Surveillance Program (NSEP)
CNPHI – facilitate communication, early notification for potential outbreaks
P/T governments and associated agencies – food safety investigations, foodborne illness investigations
FNIHB – food safety investigations, foodborne illness investigations on reserve

30
Q

Define AEFI

A

An unwanted or unexpected health effect that happens after someone receives a vaccine, which may or may not be caused by the vaccine

31
Q

Define cold chain

A

Processes used to maintain optimal conditions during the transport, storage, and handling of vaccines, keeping within the temperature range of +2 to +8 degrees C; a breach occurs when the vaccine is exposed to a temperature outside of 2-8 degrees for any length of time

32
Q

List 3 components of cold chain

A

Transport
Storage
Handling

33
Q

List 4 pieces of information to obtain when investigating a cold chain breach.

A
  • Vaccine name, lot number, expiry date
  • Date and time of incident
  • Issue (e.g., exposure to inappropriate temperature or exposure to light)
  • Length of time vaccine may have been exposed to inappropriate conditions
  • Whether any affected vaccine were administered
  • Room temperature where vaccine storage unit is
  • Current temperature inside the vaccine storage unit (and freezer)
  • Presence of water bottles in the refrigerator (storing filled water bottles on the lower shelf and the door of a refrigerator will help maintain an even, stable temperature inside the refrigerator)
  • Presence of frozen packs in the freezer
34
Q

List 4 actions to take to respond to a cold chain breach.

A
  • Notify vaccine coordinator
  • Isolate and label vaccines with “Quarantine” and date of cold chain break
  • Store the vaccine at appropriate temperatures and monitor storage
  • Transfer vaccine to an alternative storage unit/cooler if storage unit has failed (breakdown, power outage, human error, etc.)
  • Identify the source of the failure (breakdown, power outage, human error)
  • Fill out appropriate forms according to jurisdictional/local guidelines
  • Contact jurisdictional/local public health office for further guidance
35
Q

List 5 factors to consider when prioritizing a communicable disease for elimination

A

Disease of public health significance (disease factors)
Disease has limited geographical distribution (disease factors)
Humans are essential to the life cycle (disease factors)
No known animal reservoir (disease factors)
Sensitive and specific diagnostic tool to detect transmission (system factors)
Diagnosis is easy and unambiguous (system factors)
An effective intervention (system factors)
Control interventions are simple, cost effective, easy to implement (system factors)
Political commitment from governments is available (societal factors)

36
Q

List 4 reasons why a disease might be notifiable to public health?

A

There is an action associated with notification - ie. PEP
A disease defined as reportable to the WHO through the International Health Regulations
Vaccine preventable
Diseases that have been eliminated
Risk of severe outcomes
Risk of spread
Meaningful public health action can be taken (e.g. PEP for close contacts)

37
Q

List the 3 strategic goals in the 2018 Pan-Canadian STBBI Framework for Action

A

Reduce the incidence of STBBI in Canada
Improve access to testing, treatment, and ongoing care and support
Reduce stigma and discrimination that create vulnerabilities to STBBI

38
Q

List 6 of the 8 guiding principles in the 2018 Pan-Canadian STBBI Framework for Action

A

Meaningful engagement with people living with HIV and viral hepatitis and key populations
Moving towards truth and reconciliation
Integrated approach
Cultural relevance
Human rights
Health equity including equitable access to quality information and services from qualified health professionals and other front-line providers
Multi-sectoral approach
Evidence-based policy and programs

39
Q

List the 4 pillars of the 2018 Pan-Canadian STBBI Framework for Action

A

Prevention
Testing
Initiation of care
Ongoing supports

FYI:
Enabler - Enabling enviromnents
Foundation - surveillance
Foundation - Research
Foundation - Knowledge mobilization
Foundation - Monitoring and evaluation

40
Q

List 3 global HIV targets

A

Zero new HIV infections by 2030
Zero AIDS-related deaths by 2030
Zero discrimination by 2030

Alternative answer: 95-95-95 by 2025 WHO Targets
95% of people with HIV know their status
95% of people with HIV are on ART
95% on ART achieve viral suppression (< 40-50 copies/mL)

41
Q

List 3 global viral hepatitis targets

A

90% reduction in new cases of chronic viral hep B and C infections by 2030
65% reduction in hep B and C deaths by 2030
90% of viral hep B and C infections are diagnosed by 2030
80% of eligible people receiving hep B and C treatment by 2030

42
Q

List 3 global STI targets other than HIV and viral hepatitis

A

90% reduction of T. pallidum incidence globally
90% reduction in N. gonorrheae incidence globally
50 or fewer cases of congenital syphilis per 100,000 live births in 80% of countries
Sustain 90% national coverage and at least 80% in every district (or equivalent administrative unit) in countries with the HPV vaccine in their national immunization programme

43
Q

List 5 maternal risk factors for congenital syphilis

A

Younger than 20 years old
No prenatal care
Substance use (alcohol, methamphetamines, tobacco)
Lower income
Rural and remote residence
Historical trauma (including stigma and discrimination)

44
Q

List the 4 aspects of the HIV Cascade of Care

A
  1. HIV diagnosis
  2. Linked to HIV care
  3. Treatment with ART
  4. Suppressed viral load
45
Q

What are the International Health Regulations?

A

“They create rights and obligations for countries, including the requirement to report public health events. The Regulations also outline the criteria to determine whether or not a particular event constitutes a “public health emergency of international concern”. (WHO)

46
Q

List 3 clinical features associated with congenital rubella syndrome

A

Cataracts or congenital glaucoma
Congenital heart defect
SNHL
Pigmentary retinopathy
Purpura
Hepatosplenomegaly
Microcephaly
Micro-ophthalmia
Low IQ/developmental delay
Meningoencephalitis
Radiolucent bone disease
Developmental or late onset conditions such as progressive pan-encephalitis